Skip to main content
Premium Trial:

Request an Annual Quote

Save the Devils!

In a paper published online in advance in PNAS this week, the Pennsylvania State University's Stephan Schuster and his international colleagues report their whole-genome analysis of two animals of distinct geographic origin, as well as 14 complete mitochondrial genomes from both current and museum specimens, for the Tasmanian devil — which continues to face the threat of "extinction because of a contagious cancer known as Devil Facial Tumor Disease," the authors write. In its investigations, the team unearthed genomic evidence to suggest that "the observed low genetic diversity in today's population preceded the ... disease outbreak by at least 100 [years]," Schuster et al. write. The authors suggest that "using a genetically characterized breeding stock based on the genome sequence will enable preservation of the extant genetic diversity in future Tasmanian devil populations." USA Today's Elizabeth Weise says the Schuster et al. study "could help biologists create a genetically diverse ark to keep the species alive and healthy in captive breeding programs." The UK Natural History Museum's David Rollinson told BBC News that "it is a big step forward to actually get the genome sequence from this animal." He also suggested that "a similar approach could be used to study and save other endangered animals," BBC says. Reuters adds that the team does indeed plan to use whole-genome sequencing for future studies aimed at conservation in other animals.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.